Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 27, 2024 - Issue 6
2,362
Views
4
CrossRef citations to date
0
Altmetric
Review Article

A comprehensive examination of the evidence for whole of diet patterns in Parkinson's disease: a scoping review

ORCID Icon, , &

References

  • Pagano G, Ferrara N, Brooks DJ, et al. Age at onset and Parkinson disease phenotype. Neurology. 2016;86(15):1400–7. doi:10.1212/WNL.0000000000002461
  • Kouli A, Torsney KM, Kuan WL. Parkinson’s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, Greenland JC, editors. Parkinson’s disease pathogenesis and clinical aspects. Brisbane: Codon Publications; 2018. p. 3–26.
  • Sveinbjornsdottir S. The clinical symptoms of Parkinson's disease. J Neurochem. 2016;139(Suppl 1):318–24. doi:10.1111/jnc.13691
  • Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatr. 2000;69(3):308–12. doi:10.1136/jnnp.69.3.308
  • Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896–912. doi:10.1016/S0140-6736(14)61393-3
  • GBD 2016. Parkinson's disease collaborators. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):939–53. doi:10.1016/S1474-4422(18)30295-3
  • GBD 2015. Neurological disorders collaborator group. global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2017;16(11):877–97. doi:10.1016/S1474-4422(17)30299-5
  • Yang W, Hamilton JL, Kopil C, et al. Current and projected future economic burden of Parkinson’s disease in the U.S. NPJ Parkinson's Disease. 2020;6(1):15. doi:10.1038/s41531-020-0117-1
  • Ou Z, Pan J, Tang S, et al. Global trends in the incidence, prevalence, and years lived With disability of Parkinson's disease in 204 countries/territories from 1990 to 2019 [original research]. Front Public Health. 2021;9. doi:10.3389/fpubh.2021.776847.
  • Prenger MTM, Madray R, Van Hedger K, et al. Social symptoms of Parkinson’s disease. Parkinson’s Disease. 2020;2020:8846544. doi:10.1155/2020/8846544.
  • Rodríguez-Violante M, Camacho-Ordoñez A, Cervantes-Arriaga A, et al. Factors associated with the quality of life of subjects with Parkinson's disease and burden on their caregivers. Neurologia (Barcelona, Spain). 2015;30(5):257–63. doi:10.1016/j.nrl.2014.01.008
  • Perpiñá-Galvañ J, Orts-Beneito N, Fernández-Alcántara M, et al. Level of burden and health-related quality of life in caregivers of palliative care patients. Int J Environ Res Public Health. 2019;16(23):4806. doi:10.3390/ijerph16234806.
  • Zahoor I, Shafi A, Haq E. Pharmacological treatment of Parkinson’s disease. In: Stoker TB, Greenland JC, editors. Parkinson's disease: pathogenesis and clinical aspects. Brisbane: Codon Publications; 2018. p. 129–144.
  • Whitfield AC, Moore BT, Daniels RN. Classics in chemical neuroscience: levodopa. ACS Chem Neurosci. 2014;5(12):1192–7. doi:10.1021/cn5001759
  • Beckers M, Bloem BR, Verbeek MM. Mechanisms of peripheral levodopa resistance in Parkinson's disease. NPJ Parkinsons Dis. 2022;8(1):56. doi:10.1038/s41531-022-00321-y
  • Pigott JS, Kane EJ, Ambler G, et al. Systematic review and meta-analysis of clinical effectiveness of self-management interventions in Parkinson’s disease. BMC Geriatr. 2022;22(1):45. doi:10.1186/s12877-021-02656-2
  • Ernst M, Folkerts AK, Gollan R, et al. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023;1(1):Cd013856. doi:10.1002/14651858.CD013856.pub2.
  • Rocca WA. The burden of Parkinson's disease: a worldwide perspective. Lancet Neurol. 2018;17(11):928–9. doi:10.1016/S1474-4422(18)30355-7
  • Russell RD, Black LJ, Begley A. Nutrition education programs for adults with neurological diseases Are lacking: A scoping review. Nutrients. 2022;14(8):1577. doi:10.3390/nu14081577.
  • Barbaresko J, Lellmann AW, Schmidt A, et al. Dietary factors and neurodegenerative disorders: an umbrella review of meta-analyses of prospective studies. Adv Nutr. 2020;11(5):1161–73. doi:10.1093/advances/nmaa053
  • Hong CT, Chan L, Bai CH. The effect of caffeine on the risk and progression of Parkinson's disease: A meta-analysis. Nutrients. 2020;12(6):1860.
  • Seidl SE, Santiago JA, Bilyk H, et al. The emerging role of nutrition in Parkinson's disease. Front Aging Neurosci. 2014;6(36):36. doi:10.3389/fnagi.2014.00036.
  • Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, et al. Alcohol consumption and risk for Parkinson's disease: a systematic review and meta-analysis. J Neurol. 2019;266(8):1821–34. doi:10.1007/s00415-018-9032-3
  • Tamtaji OR, Taghizadeh M, Aghadavod E, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Clin Neurol Neurosurg. 2019;176:116–21. doi:10.1016/j.clineuro.2018.12.006
  • Chang MC, Kwak SG, Kwak S. Effect of dietary vitamins C and E on the risk of Parkinson's disease: A meta-analysis. Clin Nutr. 2021;40(6):3922–30. doi:10.1016/j.clnu.2021.05.011
  • Shen L. Associations between B vitamins and Parkinson's disease. Nutrients. 2015;7(9):7197–208. doi:10.3390/nu7095333
  • Talebi S, Ghoreishy SM, Jayedi A, et al. Dietary antioxidants and risk of Parkinson's disease: A systematic review and dose-response meta-analysis of observational studies. Adv Nutr. 2022;13(5):1493–504. doi:10.1093/advances/nmac001
  • Jang CH, Oh J, Lim JS, et al. Fermented Soy products: beneficial potential in neurodegenerative diseases. Foods. 2021;10(3):636. doi:10.3390/foods10030636.
  • Cheng P, Yu J, Huang W, et al. Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis. Neurol Sci. 2015;36(12):2269–75. doi:10.1007/s10072-015-2349-0
  • Boelens Keun JT, Arnoldussen IA, Vriend C, et al. Dietary approaches to improve efficacy and control side effects of levodopa therapy in Parkinson's disease: A systematic review. Adv Nutr. 2021;12(6):2265–87. doi:10.1093/advances/nmab060
  • Boulos C, Yaghi N, El Hayeck R, et al. Nutritional risk factors, microbiota and Parkinson's disease: what is the current evidence? Nutrients. 2019;11(8):1896. doi:10.3390/nu11081896.
  • Nielsen SD, Pearson NM, Seidler K. The link between the gut microbiota and Parkinson's disease: A systematic mechanism review with focus on α-synuclein transport. Brain Res. 2021;1769:147609. doi:10.1016/j.brainres.2021.147609
  • Nuzum ND, Loughman A, Szymlek-Gay EA, et al. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review. Neurosci Biobehav Rev. 2020;112:227–41. doi:10.1016/j.neubiorev.2020.02.003
  • Marć MA, Jastrząb R, Mytych J. Does the gut microbial metabolome really matter? The connection between GUT metabolome and neurological disorders. Nutrients. 2022;14:3967. DOI:10.3390/nu14193967
  • Nag N, Jelinek GA. A narrative review of lifestyle factors associated with Parkinson's disease risk and progression. Neurodegener Dis. 2019;19(2):51–9. doi:10.1159/000502292
  • Liu YH, Jensen GL, Na M, et al. Diet quality and risk of Parkinson's disease: A prospective study and meta-analysis. J Parkinsons Dis. 2021;11(1):337–47. doi:10.3233/JPD-202290
  • Trichopoulou A, Martínez-González MA, Tong TYN, et al. Definitions and potential health benefits of the Mediterranean diet: views from experts around the world. BMC Med. 2014;12(1):112. doi:10.1186/1741-7015-12-112
  • Morris MC, Tangney CC, Wang Y, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015;11(9):1015–22. doi:10.1016/j.jalz.2015.04.011
  • Agarwal P, Wang Y, Buchman AS, et al. MIND diet associated with reduced incidence and delayed progression of ParkinsonismA in Old Age. J Nutr Health Aging. 2018;22(10):1211–5. doi:10.1007/s12603-018-1094-5
  • Metcalfe-Roach A, Yu AC, Golz EC, Mihai C, et al. MIND and Mediterranean diets associated with later onset of Parkinson's disease. Mov Disord. 2021;36(4):977–84. doi:10.1002/mds.28464.
  • Hosking DE, Eramudugolla R, Cherbuin N, et al. MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study. Alzheimers Dement. 2019;15(4):581–9. doi:10.1016/j.jalz.2018.12.011.
  • Solch RJ, Aigbogun JO, Voyiadjis AG, et al. Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: a systematic review. J Neurol Sci. 2022;434:120166. doi:10.1016/j.jns.2022.120166
  • Knight E, Geetha T, Burnett D, et al. The role of diet and dietary patterns in Parkinson's disease. Nutrients. 2022;14(21):4472. doi:10.3390/nu14214472.
  • Masood W, Annamaraju P, Uppaluri KR. Ketogenic diet. Treasure Island (FL): StatPearls Publishing; 2022; [updated]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499830/.
  • Pavón S, Lázaro E, Martínez O, et al. Ketogenic diet and cognition in neurological diseases: a systematic review. Nutr Rev. 2021;79(7):802–13. doi:10.1093/nutrit/nuaa113
  • Christensen MG, Damsgaard J, Fink-Jensen A. Use of ketogenic diets in the treatment of central nervous system diseases: a systematic review. Nord J Psychiatry. 2021;75(1):1–8. doi:10.1080/08039488.2020.1795924
  • Crosby L, Davis B, Joshi S, et al. Ketogenic diets and chronic disease: weighing the benefits against the risks [review]. Front Nutr. 2021;8:702802. doi:10.3389/fnut.2021.702802.
  • Ma K, Xiong N, Shen Y, et al. Weight loss and malnutrition in patients with Parkinson's disease: current knowledge and future prospects. Front Aging Neurosci. 2018;10(1). doi:10.3389/fnagi.2018.00001.
  • Ongun N. Does nutritional status affect Parkinson's disease features and quality of life? PLOS ONE. 2018;13(10):e0205100. doi:10.1371/journal.pone.0205100
  • Sheard JM, Ash S, Mellick GD, et al. Improved nutritional status is related to improved quality of life in Parkinson’s disease. BMC Neurol. 2014;14(1):212. doi:10.1186/s12883-014-0212-1
  • Pereira J, de Queiroz Júnior JR, de Medeiros LC, et al. Sarcopenia and dynapenia is correlated to worse quality of life perception in middle-aged and older adults with Parkinson's disease. Nutr Neurosci. 2023: 1–9. doi:10.1080/1028415X.2023.2190246
  • Rajiah K, Maharajan MK, Yeen SJ, et al. Quality of life and caregivers’ burden of Parkinson's disease. Neuroepidemiology. 2017;48(3-4):131–7. doi:10.1159/000479031
  • Sheard JM, Ash S, Mellick GD, et al. Malnutrition in a sample of community-dwelling people with Parkinson’s disease. PLoS ONE. 2013;8(1):e53290. doi:10.1371/journal.pone.0053290
  • Riggare S, Höglund PJ, Hvitfeldt Forsberg H, et al. Patients are doing it for themselves: A survey on disease-specific knowledge acquisition among people with Parkinson's disease in Sweden. Health Informatics J. 2019;25(1):91–105. doi:10.1177/1460458217704248
  • Kantor D, Bright JR, Burtchell J. Perspectives from the patient and the healthcare professional in multiple sclerosis: social media and patient education. Neurol Ther. 2018;7(1):23–36. doi:10.1007/s40120-017-0087-3
  • Wicks P, Stamford J, Grootenhuis MA, et al. Innovations in e-health. Qual Life Res. 2014;23(1):195–203. doi:10.1007/s11136-013-0458-x
  • Chou WS, Oh A, Klein WMP. Addressing health-related misinformation on social media. Jama. 2018;320(23):2417–8. doi:10.1001/jama.2018.16865
  • Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73. doi:10.7326/M18-0850
  • Garousi V, Felderer M, Mäntylä MV. Guidelines for including grey literature and conducting multivocal literature reviews in software engineering. Inf Softw Technol. 2019;106:101–21. doi:10.1016/j.infsof.2018.09.006
  • Schöpfel J. Towards a Prague definition of grey literature. Twelfth International Conference on Grey Literature: Transparency in Grey Literature. Grey Tech Approaches to High Tech Issues; 2010 Dec 6–7; Prague, Czech Republic. https://archivesic.ccsd.cnrs.fr/sic_00581570/document; https://archivesic.ccsd.cnrs.fr/sic_00581570/file/GL_12_Schopfel_v5.2.pdf.
  • The EndNote Team. Endnote [64 bit]. EndNote 20. Philadelphia, PA: Clarivate; 2013.
  • Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation; ND.
  • Phillips MCL, Murtagh DKJ, Gilbertson LJ, et al. Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial. Mov Disord. 2018;33(8):1306–14. doi:10.1002/mds.27390
  • Tidman MM, White D, White T. Effects of an low carbohydrate/healthy fat/ketogenic diet on biomarkers of health and symptoms, anxiety and depression in Parkinson's disease: a pilot study. Neurodegener Dis Manag. 2022;12(2):57–66. doi:10.2217/nmt-2021-0033
  • Krikorian R, Shidler MD, Summer SS, et al. Nutritional ketosis for mild cognitive impairment in Parkinson's disease: A controlled pilot trial. Clin Park Relat Disord. 2019;1:41–7. doi:10.1016/j.prdoa.2019.07.006.
  • Koyuncu H, Fidan V, Toktas H, et al. Effect of ketogenic diet versus regular diet on voice quality of patients with Parkinson’s disease. Acta Neurol Belg. 2021;121(6):1729–32. doi:10.1007/s13760-020-01486-0
  • Lawrie S, Coe S, Mansoubi M, et al. Dietary patterns and nonmotor symptoms in Parkinson’s disease: A cross-sectional analysis. J Am Nutr. Assoc. 2022;42(4):1–10. doi:10.1080/07315724.2022.2056544.
  • Molsberry S, Bjornevik K, Hughes KC, et al. Diet pattern and prodromal features of Parkinson disease. Neurology. 2020;95(15):e2095. doi:10.1212/WNL.0000000000010523
  • Sääksjärvi K, Knekt P, Lundqvist A, et al. A cohort study on diet and the risk of Parkinson's disease: the role of food groups and diet quality. Br J Nutr. 2013;109(2):329–37. doi:10.1017/S0007114512000955
  • Mischley LK, Lau RC, Bennett RD. Role of diet and nutritional supplements in Parkinson’s disease progression. Oxid Med Cell Longevity. 2017;2017:6405278. doi:10.1155/2017/6405278
  • Alcalay RN, Gu Y, Mejia-Santana H, et al. The association between Mediterranean diet adherence and Parkinson's disease. Mov Disord. 2012;27(6):771–4. doi:10.1002/mds.24918.
  • Barichella M, Cereda E, Cassani E, et al. Dietary habits and neurological features of Parkinson's disease patients: implications for practice. Clin Nutr. 2017;36(4):1054–61. doi:10.1016/j.clnu.2016.06.020
  • Belingheri M, Chiu Y-HM, Renzetti S, et al. Relationships of nutritional factors and agrochemical exposure with Parkinson’s disease in the Province of Brescia, Italy. Int J Environ Res Public Health. 2022;19(6):3309. doi:10.3390/ijerph19063309
  • Cassani E, Barichella M, Ferri V, et al. Dietary habits in Parkinson's disease: adherence to Mediterranean diet. Parkinsonism Relat Disord. 2017;42:40–6. doi:10.1016/j.parkreldis.2017.06.007
  • Torti M, Fossati C, Casali M, et al. Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study. PLoS One. 2020;15(12):e0243612. doi:10.1371/journal.pone.0243612
  • Coe S, Spruzen S, Sanchez C, et al. A cross-sectional feasibility study of nutrient intake patterns in people With Parkinson’s compared to government nutrition guidelines. J Am Coll Nutr. 2020;39(3):187–91. doi:10.1080/07315724.2019.1633440
  • Sauerbier A, Schrag A, Martinez-Martin P, et al. Dietary variations in a multiethnic Parkinson’s disease cohort and possible influences on nonmotor aspects: a cross-sectional multicentre study. Parkinson’s Disease. 2018;2018:7274085. doi:10.1155/2018/7274085.
  • Kyrozis A, Ghika A, Stathopoulos P, et al. Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece. Eur J Epidemiol. 2013;28(1):67–77. doi:10.1007/s10654-012-9760-0
  • Maraki MI, Yannakoulia M, Stamelou M, et al. Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease. Mov Disord. 2019;34(1):48–57. doi:10.1002/mds.27489.
  • Paknahad Z, Sheklabadi E, Derakhshan Y, et al. The effect of the Mediterranean diet on cognitive function in patients with Parkinson’s disease: A randomized clinical controlled trial. Complement Ther Med. 2020;50:102366. doi:10.1016/j.ctim.2020.102366
  • Paknahad Z, Sheklabadi E, Moravejolahkami AR, et al. The effects of Mediterranean diet on severity of disease and serum total antioxidant capacity (TAC) in patients with Parkinson’s disease: a single center, randomized controlled trial. Nutr Neurosci. 2022;25(2):313–20. doi:10.1080/1028415X.2020.1751509
  • Palavra NC, Lubomski M, Flood VM, et al. Increased added sugar consumption Is common in Parkinson's disease. Front Nutr. 2021;8(628845):628845. doi:10.3389/fnut.2021.628845.
  • Baert F, Matthys C, Mellaerts R, et al. Dietary intake of Parkinson's disease patients. Front Nutr. 2020;7(105):105. doi:10.3389/fnut.2020.00105.
  • Fukushima T, Tan X, Luo Y, et al. Nutritional effects on depressive symptoms in Parkinson’s disease patients. ESPEN J. 2012;7(2):e64–e68. doi:10.1016/j.clnme.2012.02.002.
  • Hegelmaier T, Lebbing M, Duscha A, et al. Interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson’s disease. Cells. 2020;9(2):376. doi:10.3390/cells9020376
  • Barichella M, Akpalu A, Cham M, et al. Nutritional status and dietary habits in Parkinson’s disease patients in Ghana. Nutrition. 2013;29(2):470–3. doi:10.1016/j.nut.2012.09.017
  • Gupta V, Garg RK, Pant KK, et al. A study on risk factors for Parkinson׳s disease in Indian population. Bioinformation. 2014;10(6):342–6. doi:10.6026/97320630010342
  • Okubo H, Miyake Y, Sasaki S, et al. Dietary patterns and risk of Parkinson’s disease: a case–control study in Japan. Eur J Neurol. 2012;19(5):681–8. doi:10.1111/j.1468-1331.2011.03600.x.
  • Navarro-Meza M, Gabriel-Ortiz G, Pacheco-Moisés FP, et al. Dietary fat and antioxidant vitamin intake in patients of neurodegenerative disease in a rural region of Jalisco, Mexico. Nutr Neurosci. 2014;17(6):260–7. doi:10.1179/1476830513Y.0000000089
  • Strikwerda AJ, Dommershuijsen LJ, Ikram MK, et al. Diet quality and risk of Parkinson's disease: the Rotterdam Study. Nutrients. 2021;13(11):3970. doi:10.3390/nu13113970.
  • Zapała B, Stefura T, Milewicz T, et al. The role of the western diet and oral microbiota in Parkinson's disease. Nutrients. 2022;14(2):355. doi:10.3390/nu14020355.
  • Yin W, Löf M, Pedersen NL, et al. Mediterranean dietary pattern at middle age and risk of Parkinson's disease: a Swedish cohort study. Mov Disord. 2021;36(1):255–60. doi:10.1002/mds.28314.
  • National Institutes of Health. Parkinson’s Disease: Causes, Symptoms, and Treatments US: NIH; 2022 [cited 2022 Nov 25]. Available from: https://www.nia.nih.gov/health/parkinsons-disease
  • Health Direct Australia. Parkinson's Disease Australia: Health Direct Australia; 2021 [cited 2022 Nov 25]. Available from: https://www.healthdirect.gov.au/parkinsons-disease
  • Williamson G. The role of polyphenols in modern nutrition. Nutr Bull. 2017;42(3):226–35. doi:10.1111/nbu.12278
  • Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017;8(2):172–84. doi:10.1080/19490976.2017.1290756
  • Chang KH, Chen CM. The role of oxidative stress in Parkinson's disease. Antioxidants (Basel). 2020;9(7):597. doi:10.3390/antiox9070597.
  • Park H-A, Ellis AC. Dietary antioxidants and Parkinson's disease. Antioxidants (Basel, Switzerland). 2020;9(7):750. doi:10.3390/antiox9070570.
  • Swann OG, Kilpatrick M, Breslin M, et al. Dietary fiber and its associations with depression and inflammation. Nutr Rev. 2020;78(5):394–411. doi:10.1093/nutrit/nuz072
  • Nuzum ND, Szymlek-Gay EA, Loke S, et al. Differences in the gut microbiome across typical ageing and in Parkinson's disease. Neuropharmacology. 2023;235:109566. doi:10.1016/j.neuropharm.2023.109566
  • Stocchi F, Torti M. Chapter twenty-seven - constipation in Parkinson's disease. In: Chaudhuri KR, Titova N, editors. International review of neurobiology. Cambridge: Academic Press; 2017. p. 811–26.
  • Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov Disord. 2009;24(13):1881–92. doi:10.1002/mds.22705.
  • Scorza FA, de Almeida AG, Scorza CA, et al. Water intake in Parkinson's disease: addressing a neglected problem. Aging Clin Exp Res. 2022;34(12):3161–2. doi:10.1007/s40520-022-02228-3
  • Virmani T, Tazan S, Mazzoni P, et al. Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease. J Clin Mov Disord. 2016;3(1):8. doi:10.1186/s40734-016-0036-9
  • Kempster PA, Perju-Dumbrava L. The thermodynamic consequences of Parkinson's disease [review]. Front Neurol. 2021;12:685314. doi:10.3389/fneur.2021.685314.
  • Kacprzyk KW, Milewska M, Zarnowska A, et al. Prevalence of malnutrition in patients with Parkinson's disease: a systematic review. Nutrients. 2022;14(23):5194. doi:10.3390/nu14235194.
  • De Rui M, Inelmen EM, Trevisan C, et al. Parkinson’s disease and the non-motor symptoms: hyposmia, weight loss, osteosarcopenia. Aging Clin Exp Res. 2020;32(7):1211–8. doi:10.1007/s40520-020-01470-x
  • Bril A, Perez-Lloret S, Rossi M, et al. A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson’s disease. NPJ Parkinson's Disease. 2017;3(1):17. doi:10.1038/s41531-017-0018-0